Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2005
03/17/2005US20050058720 Administering thiomolybdate to bind copper and form tripartite complex with protein; ocular, corneal or retinal/choroidal neovascularization, glaucoma, diabetes, delayed wound healing, burns, Osler-Weber Syndrome, psoriasis, parasitic diseases or atherosclerosis; antitumor and anticarcinogenic agents
03/17/2005US20050058706 Delayed release pharmaceutical composition containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol
03/17/2005US20050058702 Compositions capable of facilitating penetration across a biological barrier
03/17/2005US20050058698 The use of liposomes for treatment of inflammation and autoimmune disorders in mammals by reduction of Tumor necrosis factor
03/17/2005US20050058697 Delivery of drug active material to cells with penetration and peptides in vehicles
03/17/2005US20050058696 Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
03/17/2005US20050058692 Biofunctional fibers
03/17/2005US20050058679 Cosmetic preparation with 2-methyl-1,3-propanediol, or pentanediol or hexanediol with antioxidant and uv filter for skin moisturizer
03/17/2005US20050058673 Decontamination of vegetables, meats or fruits by disinfection of such with antimicrobial solution containing lipid and enhancer such as bacteriocins, sugars and enzymes
03/17/2005US20050058671 synergistic efficacy; polar lipid supplement which contains significant amounts of polar lipids and antioxidants; soluble beta-glucan fiber; and amino acid such as L-threonine
03/17/2005US20050058669 Skin care topical ointment
03/17/2005US20050058667 Adjuvants for use in vaccines
03/17/2005US20050058657 Vaccines for treatment of Aids
03/17/2005US20050058623 Use of gp130 activators in diabetic neuropathy
03/17/2005US20050058620 Modified bio-related substance, process for producing the same, and intermediate
03/17/2005US20050058607 Control of process humidity to produce large, porous particles
03/17/2005US20050058606 Stable drug solution for aerosol administering; contining acid
03/17/2005US20050058603 Biocompatible polymeric shell around hollow core; containing magnetic resonance imaging contrast agents
03/17/2005DE69822327T2 Transdermales arzneistoff-abgabesystem für ein entzündungshemmendes analgetisches mittel enthaltend diclofenac diethylammonium salz, und verfahren zu dessen herstellung The transdermal drug-delivery system-containing medium for anti-inflammatory analgesic diclofenac diethylammonium salt, and process for its manufacture
03/17/2005DE102004040243A1 Transport system for overcoming the blood-brain barrier, useful for the treatment and diagnosis of brain-specific diseases, comprises chitin, chitosan, chitosan oligosaccharides or glucosamine
03/17/2005DE10012908B4 Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung Stabilized supersaturated matrix transdermal therapeutic systems and processes for their preparation
03/17/2005CA2538691A1 Process for producing polysaccharide for conjugate vaccine
03/17/2005CA2538382A1 Antimicrobial compositions and methods
03/17/2005CA2538159A1 Polyamine-metal chelator conjugates
03/17/2005CA2537802A1 Composition containing nanoparticles containing water-soluble basic drug encapsulated therein
03/17/2005CA2537607A1 Granular sustained release preparation and production thereof
03/17/2005CA2537480A1 Novel orally administered dosage form for 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] -ethyl proprionate and salts thereof
03/17/2005CA2537290A1 Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
03/17/2005CA2536061A1 Polymeric systems for controlled drug therapy
03/17/2005CA2526398A1 Human monoclonal antibodies against bacillus anthracis protective antigen
03/16/2005EP1514884A1 Block copolymer comprising a vinyllactam block, cosmetic composition and use of this polymer in cosmetics
03/16/2005EP1514877A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
03/16/2005EP1514560A1 Process for producing block copolymer/drug composite
03/16/2005EP1514556A1 Botulinum toxin pharmaceutical compositions
03/16/2005EP1514549A1 Powdery respiratory tonic composition
03/16/2005EP1514546A1 Medicament compositions based on tiotropium salts and on salmeterol salts
03/16/2005EP1514538A1 Sustained-release composition, process for producing the same and preparation thereof
03/16/2005EP1514532A1 Block copolymer comprising a vinyllactam block, cosmetic composition and use of this polymer in cosmetics
03/16/2005EP1514106A1 Targeted therapeutic proteins
03/16/2005EP1513862A2 Novel derivatives of androstane and androstene with ascorbic acid and use thereof in treating or preventing various conditions, diseases, and disorders
03/16/2005EP1513853A2 Cardiolipin compositions, methods of preparation and use
03/16/2005EP1513587A1 Self-administered contraceptive injection of oily solution
03/16/2005EP1513560A2 Method of magnetically manipulating a cell with magnetisable particles
03/16/2005EP1513557A2 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases
03/16/2005EP1513556A1 A process for the preparation of piroxicam: b-cyclodextrin inclusion compounds
03/16/2005EP1513540A1 Pharmaceutical compositions comprising abacavir and lamivudine
03/16/2005EP1513532A1 Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein
03/16/2005EP1513512A2 Soluble stable pharmaceutical composition for the administration of hiv protease inhibitors and a process for the preparation of concentrated pharmaceutical compositions for the administration of hiv protease inhibitors.
03/16/2005EP1513511A1 (2s)-2-amino-4- [2-(ethanimidoylamino)ethyl]thio butanoic acid, a nitric oxide synthase inhibitor, in stabilized pharmaceutical dosage forms
03/16/2005EP1513509A2 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
03/16/2005EP1513507A1 Transdermal analgesic systems with reduced abuse potential
03/16/2005EP1513506A1 Targeting system comprising uniformly-sized nanoparticles with at least one polymer and at least one positively-charged polysaccharide and preparation method thereof
03/16/2005EP1513505A1 An improved modified release preparation
03/16/2005EP1513503A1 Extended release formulation of divalproex sodium
03/16/2005EP1513502A1 Combination therapy for respiratory disorders
03/16/2005EP1513500A2 Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
03/16/2005EP1513499A1 Ibuprofen suspension
03/16/2005EP1513497A2 Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
03/16/2005EP1513496A1 Immediate release pharmaceutical formulation
03/16/2005EP1513495A1 Modified release pharmaceutical formulation
03/16/2005EP1513494A2 Film-shaped mucoadhesive administration form for administering cannabis active ingredients
03/16/2005EP1513493A2 Analgesics
03/16/2005EP1474085A4 In situ bonds
03/16/2005EP1465989A4 Growth factor modified protein matrices for tissue engineering
03/16/2005EP1242095A4 Antimicrobial compositions and methods of use
03/16/2005EP1204423B1 Therapeutic antibody against muc-1 antigen and methods for their use
03/16/2005EP1198508B1 Preparations containing no cross-linking agents
03/16/2005EP1189640B1 Complex of eletriptan and sulphobutylether-cyclodextrin and its use for the treatment of migraine
03/16/2005EP1185502B1 Polyhydroxy diamine surfactants and their use in gene transfer
03/16/2005EP1165134B1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers
03/16/2005EP1140054B1 Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
03/16/2005EP1135125B1 Controlled-release dosage forms comprising zolpidem or a salt thereof
03/16/2005EP1097922B1 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient
03/16/2005EP1044016B1 Stabilised insulin compositions
03/16/2005EP0774964B1 Controlled local delivery of chemotherapeutic agents for treating solid tumors
03/16/2005CN1596313A Humanized collagen antibodies and related methods
03/16/2005CN1596248A Phenoxy amine compounds and compositions for delivering active agents
03/16/2005CN1596141A Conjugated anti-psychotic drugs and uses thereof
03/16/2005CN1596129A Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate
03/16/2005CN1596128A Pharmaceutical compositions of 5, 7, 14-triazatetracyclo[10.3.1.0(2, 11).0(4, 9)]-hexadeca-2(11)3, 5, 7, 9-pentaene
03/16/2005CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
03/16/2005CN1596124A Delivery system for biological component
03/16/2005CN1596121A Prevention and treatment of restenosis by local administration of drug
03/16/2005CN1596120A Medicinal compositions for nasal absorption
03/16/2005CN1596108A Aqueous ECABET sodium solution preparation
03/16/2005CN1596105A Transdermal therapeutic systems containing steroid hormones and propylene glycol monocaprylate
03/16/2005CN1596104A Modified release dosage forms
03/16/2005CN1596103A Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type II diabetes mellitus
03/16/2005CN1596102A Regulation dosage forms
03/16/2005CN1596101A Fondant composition contained dosage forms
03/16/2005CN1596100A Edible composition and dosage form comprising an edible shell
03/16/2005CN1594420A Novel powdered polymer, method for its preparation, and use as a thickener
03/16/2005CN1594332A Glycyrrhetic acid and phospholipid composites of glycyrrhetate and process for preparing same
03/16/2005CN1593661A Injectable pharmaceutical slow-release carrier and preparation method thereof
03/16/2005CN1593660A Injectable pharmaceutical slow-release carrier and preparation method thereof
03/16/2005CN1593659A Coupled compound of 5-methyl-morpholine-3-amino-2-oxazolidinone and preparation method thereof
03/16/2005CN1593658A Coupled compound of 3-amino-2-oxazolidinone and preparation method thereof
03/16/2005CN1593657A Production method of freeze dried chickenpox attenuated live vaccine and products therefrom
03/16/2005CN1593591A Method for preparing cyclodextrin inclusion compound of silybum mariamum extract and medicinal formulation thereof
03/16/2005CN1593459A Process for preparing arsenic magnetized nanometer glutin minipill
1 ... 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 ... 1712